Nanocatalytic NO gas therapy against orthotopic oral squamous cell carcinoma by single iron atomic nanocatalysts

References

• Cramer JD, Burtness B, Le QT, et al. The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol. 2019 Nov;16(11):669–16. doi: 10.1038/s41571-019-0227-z
   PubMed Web of Science ®Google Scholar
• Solomon B, Young RJ, Rischin D. Head and neck squamous cell carcinoma: genomics and emerging biomarkers for immunomodulatory cancer treatments. Semin Cancer Biol. 2018 Oct;52(Pt 2):228–240. doi: 10.1016/j.semcancer.2018.01.008
   PubMed Web of Science ®Google Scholar
• Chow LQM, Longo DL. Head and neck cancer. N Engl J Med. 2020 Jan 2;382(1):60–72. doi: 10.1056/NEJMra1715715
   PubMed Web of Science ®Google Scholar
• Machiels JP, René Leemans C, Golusinski W, et al. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020 Nov;31(11):1462–1475. doi: 10.1016/j.annonc.2020.07.011
   PubMed Web of Science ®Google Scholar
• Taberna M, Mena M, Pavón MA, et al. Human papillomavirus-related oropharyngeal cancer. Ann Oncol. 2017 Oct 1;28(10):2386–2398. doi: 10.1093/annonc/mdx304
   PubMed Web of Science ®Google Scholar
• Cohen EEW, Soulières D, Le Tourneau C, et al. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet. 2019 Jan 12;393(10167):156–167. doi: 10.1016/s0140-6736(18)31999-8
   PubMed Web of Science ®Google Scholar
• Driehuis E, Kolders S, Spelier S, et al. Oral mucosal organoids as a potential platform for personalized cancer therapy. Cancer Discov. 2019 Jul;9(7):852–871. doi: 10.1158/2159-8290.Cd-18-1522
   PubMed Web of Science ®Google Scholar
• Hanna GJ, O’Neill A, Shin KY, et al. Neoadjuvant and adjuvant Nivolumab and Lirilumab in patients with recurrent, resectable squamous cell carcinoma of the head and neck. Clin Cancer Res. 2022 Feb 1;28(3):468–478. doi: 10.1158/1078-0432.Ccr-21-2635
   PubMed Web of Science ®Google Scholar
• Graboyes EM, Kompelli AR, Neskey DM, et al. Association of treatment delays with survival for patients with head and neck cancer: a systematic review. JAMA Otolaryngol–Head Neck Surg. 2019 Feb 1;145(2):166–177. doi: 10.1001/jamaoto.2018.2716
   PubMed Web of Science ®Google Scholar
• Johnson DE, Burtness B, Leemans CR, et al. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020 Nov 26;6(1):92. doi: 10.1038/s41572-020-00224-3
   PubMed Web of Science ®Google Scholar
• Lee NY, Ferris RL, Psyrri A, et al. Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet Oncol. 2021 Apr;22(4):450–462. doi: 10.1016/s1470-2045(20)30737-3
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhou H, Zhu X, et al. Simultaneous oxidative and reductive reactions in one system by atomic design. Nat Catal. 2021 Feb;4(2):134–143. doi: 10.1038/s41929-020-00563-0
   Web of Science ®Google Scholar
• Tang Z, Zhao P, Wang H, et al. Biomedicine meets Fenton chemistry. Chem Rev. 2021;121(4):1981–2019. doi: 10.1021/acs.chemrev.0c00977
   PubMed Web of Science ®Google Scholar
• Li L, Chang X, Lin X, et al. Theoretical insights into single-atom catalysts. Chem Soc Rev. 2020 Nov 21;49(22):8156–8178. doi: 10.1039/d0cs00795a
   PubMed Web of Science ®Google Scholar
• Wang L, Yang Q, Huo M, et al. Engineering single-atomic iron-catalyst-integrated 3D-Printed bioscaffolds for osteosarcoma destruction with antibacterial and bone defect regeneration bioactivity. Adv Mater. 2021;33(31):e2100150. doi: 10.1002/adma.202100150
   PubMed Web of Science ®Google Scholar
• Singh B, Gawande M, Kute A, et al. Single-atom (iron-based) catalysts: synthesis and applications. Chem Rev. 2021;121(21):13620–13697. doi: 10.1021/acs.chemrev.1c00158
   PubMed Web of Science ®Google Scholar
• Liu P, Huo M, Shi J. Nanocatalytic medicine of iron-based nanocatalysts. CCS Chem. 2021;3(2):2445–2463. doi: 10.31635/ccschem.020.202000519
   Google Scholar
• Huo M, Wang L, Zhang H, et al. Construction of single-iron-atom nanocatalysts for highly efficient catalytic antibiotics. Small. 2019 Aug;15(31):e1901834. doi: 10.1002/smll.201901834
   PubMed Web of Science ®Google Scholar
• Zhang H, Li J, Chen Y, et al. Magneto-electrically enhanced intracellular catalysis of FePt-FeC heterostructures for chemodynamic therapy. Adv Mater. 2021;33(17):e2100472. doi: 10.1002/adma.202100472
   PubMed Web of Science ®Google Scholar
• Fu L, Wan Y, Qi C, et al. Nanocatalytic theranostics with glutathione depletion and enhanced reactive oxygen species generation for efficient cancer therapy. Adv Mater. 2021;33(7):e2006892. doi: 10.1002/adma.202006892
   PubMed Web of Science ®Google Scholar
• Huo M, Wang L, Wang Y, et al. Nanocatalytic tumor therapy by single-atom catalysts. ACS Nano. 2019 Feb 26;13(2):2643–2653. doi: 10.1021/acsnano.9b00457
   PubMed Web of Science ®Google Scholar
• Fu LH, Wan Y, Qi C, et al. Nanocatalytic theranostics with glutathione depletion and enhanced reactive oxygen species generation for efficient cancer therapy. Adv Mater. 2021 Feb;33(7):e2006892. doi: 10.1002/adma.202006892
   PubMed Web of Science ®Google Scholar
• Palmieri EM, Gonzalez-Cotto M, Baseler WA, et al. Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase. Nat Commun. 2020 Feb 4;11(1):698. doi: 10.1038/s41467-020-14433-7
   PubMed Web of Science ®Google Scholar
• Lundberg J, Weitzberg E. Nitric oxide signaling in health and disease. Cell. 2022;185(16):2853–2878. doi: 10.1016/j.cell.2022.06.010
   PubMed Web of Science ®Google Scholar
• Carlström M. Nitric oxide signalling in kidney regulation and cardiometabolic health. Nat Rev Nephrol. 2021;17(9):575–590. doi: 10.1038/s41581-021-00429-z
   PubMed Web of Science ®Google Scholar
• Yang C, Mu G, Zhang Y, et al. Supramolecular nitric oxide depot for hypoxic tumor vessel normalization and radiosensitization. Adv Mater. 2022;34(37):e2202625. doi: 10.1002/adma.202202625
   PubMed Web of Science ®Google Scholar
• Weinstain R, Slanina T, Kand D, et al. Visible-to-NIR-Light activated release: from small molecules to nanomaterials. Chem Rev. 2020 Dec 23;120(24):13135–13272. doi: 10.1021/acs.chemrev.0c00663
   PubMed Web of Science ®Google Scholar
• Kim T, Nah Y, Kim J, et al. Nitric-oxide-modulatory materials for biomedical applications. Acc Chem Res. 2022;55(17):2384–2396. doi: 10.1021/acs.accounts.2c00159
   PubMed Web of Science ®Google Scholar
• Zhou H, Premont R, Stamler J. The manifold roles of protein S-nitrosylation in the life of insulin. Nat Rev Endocrinol. 2022;18(2):111–128. doi: 10.1038/s41574-021-00583-1
   PubMed Web of Science ®Google Scholar
• Sung Y, Jin P, Chu L, et al. Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies. Nat Nanotech. 2019;14(12):1160–1169. doi: 10.1038/s41565-019-0570-3
   PubMed Web of Science ®Google Scholar
• Seth P, Hsieh P, Jamal S, et al. Regulation of MicroRNA machinery and development by interspecies S-Nitrosylation. Cell. 2019;176(5):1014–1025.e12. doi: 10.1016/j.cell.2019.01.037
   PubMed Web of Science ®Google Scholar
• Lehnert N, Kim E, Dong H, et al. The biologically relevant coordination chemistry of iron and nitric oxide: electronic structure and reactivity. Chem Rev. 2021;121(24):14682–14905. doi: 10.1021/acs.chemrev.1c00253
   PubMed Web of Science ®Google Scholar
• Narni-Mancinelli E, Vivier E. Advancing natural killer therapies against cancer. Cell. 2022;185(9):1451–1454. doi: 10.1016/j.cell.2022.04.006
   PubMed Web of Science ®Google Scholar
• Gamero-Quijano A, Bhattacharya S, Cazade P, et al. Modulating the pro-apoptotic activity of cytochrome c at a biomimetic electrified interface. Sci Adv. 2021;7(45):eabg4119. doi: 10.1126/sciadv.abg4119
   PubMed Web of Science ®Google Scholar
• Glimmers of hope for targeting p53. Cancer Discov. 2022;12(8):OF5–OF5. doi: 10.1158/2159-8290.Cd-nd2022-0009
   Google Scholar
• Eisenstein M. p53: an anticancer protein’s chequered past and promising future. Nature. 2022;603(7899):S1. doi: 10.1038/d41586-022-00565-x
   PubMedGoogle Scholar
• Garciaz S, Guirguis A, Müller S, et al. Pharmacologic reduction of mitochondrial iron triggers a noncanonical BAX/BAK-Dependent cell death. Cancer Discov. 2022;12(3):774–791. doi: 10.1158/2159-8290.Cd-21-0522
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Galluzzi L. BAX and BAK dynamics control mitochondrial DNA release during apoptosis. Cell Death Differ. 2022;29(6):1296–1298. doi: 10.1038/s41418-022-00985-2
   PubMed Web of Science ®Google Scholar
• Li X, Straub J, Medeiros T, et al. Mitochondria shed their outer membrane in response to infection-induced stress. Science. 2022;375(6577):eabi4343. doi: 10.1126/science.abi4343
   PubMed Web of Science ®Google Scholar
• Bock F, Tait S. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol. 2020;21(2):85–100. doi: 10.1038/s41580-019-0173-8
   PubMed Web of Science ®Google Scholar
• Rosier B, Markvoort A, Gumí Audenis B, et al. Proximity-induced caspase-9 activation on a DNA origami-based synthetic apoptosome. Nat Catal. 2020;3(3):295–306. doi: 10.1038/s41929-019-0403-7
   PubMed Web of Science ®Google Scholar
• Han C, Liu Z, Zhang Y, et al. Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling. Nat Immunol. 2020;21(5):546–554. doi: 10.1038/s41590-020-0641-5
   PubMed Web of Science ®Google Scholar